IL-3 is a novel target to interfere with tumor vasculature

Frontiers Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer

Cancers, Free Full-Text

HLA-G/LILRBs: A Cancer Immunotherapy Challenge: Trends in Cancer

Frontiers Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives

Frontiers Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers

IL-3 is a novel target to interfere with tumor vasculature - Document - Gale Academic OneFile

IJMS, Free Full-Text

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

Targeting the tumor stroma for cancer therapy, Molecular Cancer

JCI Insight - JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8

Hallmarks of Cancer: The Next Generation: Cell

IL-3 is a novel target to interfere with tumor vasculature

Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells